CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) ("Chicago Atlantic" or the "Company"), a commercial mortgage real estate investment trust, today announced its results for the first quarter ended March 31, 2025. Peter Sack, Co-Chief Executive Officer, noted, "We have entered 2025 much like we did in 2024 with significant volatility in the financial services sector and within the cannabis industry. The broader sentiment in cannabis is more muted than most pa ...

Core Viewpoint - Spectral Medical Inc. has secured a non-dilutive financing agreement with Vantive US Healthcare LLC for up to US$10 million to support the commercialization of its blood filtration therapy, Toraymyxin™ (PMX) [2][4][5]. Financing Details - The financing consists of a senior secured promissory note with a total principal amount of up to US$10 million, which can be drawn in up to four tranches [2][3]. - The first tranche of US$4 million was triggered on May 6, 2025, upon the execution of the agreement [4]. - The remaining tranches are contingent upon specific milestones outlined in the agreement [4]. Company Strategy and Milestones - The funds will support Spectral's evidence generation strategy and the path to commercialization of PMX, which is designed to remove endotoxin from the bloodstream in patients with sepsis [3][4]. - The company does not anticipate needing additional funding to meet key upcoming milestones, including the release of topline results and U.S. FDA submission [4]. Management Commentary - The CEO of Spectral expressed gratitude for the partnership with Vantive, emphasizing the non-dilutive nature of the funding and the alignment between the two companies [5]. Product Overview - PMX is a therapeutic hemoperfusion device that has been approved for use in Japan and Europe and has been utilized over 360,000 times [11]. - The device is currently seeking U.S. FDA approval and has received Breakthrough Device Designation for the treatment of endotoxic septic shock [11]. Clinical Trial Information - The Tigris Trial is a confirmatory study comparing PMX in addition to standard care versus standard care alone, designed as a 2:1 randomized trial involving 150 patients [12].

城投随笔系列 城投退名单后新发怎么样了？ 2025 年 05 月 07 日 ➢ "退名单"进展如何？ 2024 年 9 月末起，陆续有主体公开发布"退名单"并征求金融债权人意见 的公告。截至 2025 年 4 月 30 日，公开征求债权人意见"退名单"的这类主体 共有 39 家，其中发债主体 25 家，非发债主体 14 家。 从公告节奏来看，此类公告集中于 2024 年 9-12 月，2025 年以来仅有 6 家主体公告。 因而另一方面，我们亦需关注公开发布退出融资平台名单公告的主体。此 类公告不包含征求金融债权人意见的内容，多表述为："公司自公告之日起正式 退出政府融资平台，不再承担政府融资职能。" 统计 2024 年 9 月以来发布此类公告的主体，截至 2025 年 4 月 30 日，共 有 24 家主体公开发布此类"退名单"公告，其中发债主体有 2 家，非发债主体 有 22 家。从公告节奏来看，2025 年 3-4 月此类公告明显增多。 此外，从各地方政府的表述中可见地方正在积极推进融资平台的退出任 务，不少区域在政府工作报告、预算执行情况报告中阐述相关内容。 ➢ "市场化经营主体"有哪些？ 2023 ...

市场概况 5月6日两市ETF两融余额为1003.8亿元，较前一交易日增加1.7亿元。其中融资余额为954.76亿元，较前一交易日增加4524.16万元；融券余额为49.04亿元， 较前一交易日增加1.24亿元。 分市场来看，沪市ETF两融余额为655.7亿元，较前一交易日增加4604.04万元。其中融资余额为613.72亿元，较前一交易日减少5759.87万元；融券余额为 41.98亿元，较前一交易日增加1.04亿元。深市ETF两融余额为348.1亿元，较前一交易日增加1.24亿元。其中融资余额为341.04亿元，较前一交易日增加1.03 亿元；融券余额为7.06亿元，较前一交易日增加2072.48万元。 ETF融资融券余额 5月6日ETF两融余额前三位分别为：华安易富黄金ETF(88.41亿元)、易方达黄金ETF(70.63亿元)和华夏恒生(QDII-ETF)(53.89亿元)，前10具体见下表： | 代码 | 基金名称 | | --- | --- | | 518880.SH | 华安易富黄金ETF | | 159934.SZ | 易方达黄金ETF | | 159920.SZ | 华夏恒生(QDII-ETF ...

(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) MONTREAL, May 06, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") reports its financial and operating results for the three months ended March 31, 2025 ("Q1 2025"). Q1 2025 HIGHLIGHTS Operating, Financial and Corporate Updates: As of March 31, 2025, the Company had approximately $77.6 million in cash and cash equivalents. Approximately $35.7 million (US$25.0 millio ...

FIRST QUARTER 2025 LEADERSHIP MANDI HOGAN SVP, Marketing WENDY SIMPSON Executive Chairman PAM KESSLER Co-President and Co-CEO CLINT MALIN Co-President and Co-CEO CECE CHIKHALE EVP, Chief Financial Officer, Treasurer and Secretary DAVID BOITANO EVP, Chief Investment Officer GIBSON SATTERWHITE EVP, Asset Management MIKE BOWDEN SVP, Investments BOARD OF DIRECTORS RENEWAL AND SUPPLEMENTAL OPERATING AND FINANCIAL DATA TRANSITION | WENDY SIMPSON | Executive Chairman | | --- | --- | | CORNELIA CHENG | ESG Committe ...

DETROIT, May 5, 2025 /PRNewswire/ --General Motors (NYSE: GM) announced today the pricing of three series of senior unsecured fixed rate notes for a total of $2.0 billion. These notes include $750.0 million of 5.350% notes due in 2028, $750.0 million of 5.625% notes due in 2030 and $500.0 million of 6.250% notes due in 2035. The offering is expected to settle on May 7, 2025.GM intends to use the net proceeds from the sale of the notes for general corporate purposes, including to refinance a portion of the $ ...

Core Viewpoint - The company is on track with project development and has experienced strong tailwinds in Q1 2025, despite external challenges [1][19]. Project Development and Financing - The company aims to complete construction of the Northern Pipeline by the end of 2026 and the Southern Pipeline by the end of 2027, with an aggressive schedule in place [2]. - Key objectives in Q1 included establishing new companies for project development and securing a lead project investor to raise capital and fund construction [3]. - A $20 million equity raise was closed in Q1 to cover capital costs and development expenses, ensuring the company remains on schedule [9]. Strategic Decisions and Market Positioning - The company secured a deal to purchase 180 miles of steel pipe from the Keystone XL project, which is not subject to the 25% tariffs on imported steel announced by President Trump, thus mitigating project cost risks [4]. - The company delayed permit applications until the new administration was in place, anticipating a more efficient review process under the Trump Administration, which is expected to provide a tailwind for project development [5]. - The company locked in linear generation technology that qualifies for a 50% Investment Tax Credit (ITC) on approximately $120 million in expected costs, which is crucial for securing project investors [6]. Joint Powers Authority and Municipal Financing - The Victor Valley Wastewater Reclamation Authority voted to form a Joint Powers Authority (JPA) to support municipal financing for the project, allowing access to municipal debt for construction financing [11]. ATEC Operations and Market Growth - ATEC completed delivery on the 60MGD Central Utah treatment project and opened a new building to double its production capacity, indicating growth in operations [12]. - The groundwater remediation market in the U.S. is projected to grow at a CAGR of 8.4% to $163.4 billion by 2027, with ATEC's opportunities in various stages of project development increasing significantly in Q1 [13]. Cadiz Ranch Developments - The company is building out wellfield infrastructure at Cadiz Ranch and assisting in the permit process for a hydrogen production facility, with interest from other developers for additional facilities [17][18].

LONDON, May 05, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces today that on May 2, 2025, its subsidiaries Navigator Gas L.L.C. and Othello Shipping Company S.A. (the “Borrowers”) entered into a senior secured term loan and revolving credit facility (the “Facility Agreement”), with Nordea Bank Abp filial i Norge, Danish Ship Finance A/S, Da ...

STILLWATER, Okla., May 05, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the closing of its previously announced private investment in public equity (PIPE) financing. The PIPE is with a single institutional investor for total gross proceeds of $75 million. The Company intends to use the proceeds from the offering to fund capital expenditures for its magnet manufacturing facility in Stillwater, Oklahoma, as well as for working capital and operating expens ...